This research evaluates receptor-binding specificity and antigenicity in genotype D1.1 A(H5N1) influenza virus, indicating its potential for human adaptation.
Clade 2.3.4.4b A(H5N1) influenza viruses continue to expand their host range and pose increasing public health concerns. A case of severe human infection with genotype D1.1 A(H5N1) with HÀ substitutions was diagnosed in British Columbia. It is important to monitor receptor-binding specificity and antigenicity of emerging variants of circulating influenza A(H5N1) viruses. To evaluate potential human adaptation of this virus, we enriched HA-variant subpopulations and assessed sialic acid receptor usage via glycan microarray, solid-phase assays, and biolayer interferometry. All variants bound exclusively to avian-type sialic acid receptors. The antigenicity of the tested A(H5N1) variants was covered by candidate vaccine viruses.
No takes yet. Share an insight, caveat, or question.
Kandeil et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: